An anti-rheumatic agent T-614 inhibits NF-κB activation in LPS- and TNF-α-stimulated THP-1 cells without interfering with IκBα degradation

Yukihiko Aikawa(Lead Chemical (Japan)), Masakazu Yamamoto(Lead Chemical (Japan)), Takuya Yamamoto(Lead Chemical (Japan)), Kanehisa Morimoto(Lead Chemical (Japan)), Kéiichi Tanaka(Lead Chemical (Japan))
Inflammation Research
April 1, 2002
Cited by 112

Abstract


Related Papers

No related papers found

Powered by citation graph analysis